First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Not Applicable

Completed

• Conditions: Colonic Neoplasms; Rectal Neoplasms

• Registration Number: NCT00537901
• Lead Sponsor: King Faisal Specialist Hospital & Research Center

Brief Summary

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10
• Study First Submitted: 2007-10-01
• Study First Submitted QC: 2007-10-01
• Study First Posted: 2007-10-02
• Primary Completion: 2013-10
• Study Completion: 2013-10
• Status Verified: 2015-12
• Last Update Submitted: 2015-12-16
• Last Update Posted: 2015-12-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients with metastatic cancer of colon or rectum

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Effectiveness	overall

Secondary Outcome Measures

Name	Time	Method
Quality of life	overall